These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8546844)

  • 1. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
    Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
    APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: prognostic value in 48 patients.
    Dreinhöfer KE; Akerman M; Willén H; Anderson C; Gustafson P; Rydholm A
    Int J Cancer; 1994 Nov; 59(3):379-82. PubMed ID: 7927945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
    Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
    J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
    Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Baldetorp B; Fernö M; Alvegård T; Rydholm A
    APMIS; 1994 Dec; 102(12):915-24. PubMed ID: 7888160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
    Haerslev T; Jacobsen GK; Zedeler K
    Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.
    Hoyt JW; Gown AM; Kim DK; Berger MS
    J Neurooncol; 1995; 24(2):163-9. PubMed ID: 7562003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
    Yang WI; Efird JT; Quintanilla-Martinez L; Choi N; Harris NL
    Hum Pathol; 1996 Jan; 27(1):70-6. PubMed ID: 8543314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of Ki-67 antigen and c-myc oncoprotein in malignant fibrous histocytoma.
    Brinck U; Stachura J; Kellner S; Schauer A
    Anticancer Res; 1995; 15(5B):1915-9. PubMed ID: 8572578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
    Cher ML; Chew K; Rosenau W; Carroll PR
    Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
    Elpek GO; Gelen T; Aksoy NH; Karpuzoglu T; Keles N
    Pathol Oncol Res; 2000; 6(1):59-64. PubMed ID: 10749590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma.
    Engellau J; Akerman M; Anderson H; Domanski HA; Rambech E; Alvegård TA; Nilbert M
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):358-63. PubMed ID: 11759064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
    Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
    J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
    Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.